1651. Erleada-PSUSA-00010745-202502 1652. Jemperli-H-C-PSUSA/00010931/202504 1653. Myfenax-PSUSA-00010550-202505 1654. Loqtorzi-PSUSA-00011094-202506 1655. Cuprymina: EPAR - Summary for the public 1656. Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals): EPAR - Summary for the public 1657. Xromi-H-C-PSUSA-00001692-202406 1658. Jardiance-H-C-PSUSA-00010388-202404 1659. ProQuad-H-C-PSUSA-00001936-202409 1660. Padcev-PSUSA-00010989-202412 1661. Jayempi-PSUSA-00000275-202412 1662. Evrenzo-PSUSA-00010955-202412 1663. Talvey-H-C-PSUSA-00000099-202408 1664. Adasuve-H-C-PSUSA-00010113-202408 1665. Zynyz-PSUSA-00011059-202503 1666. Retsevmo-PSUSA-00010917-202505 1667. Porcilis Porcoli Diluvac Forte: EPAR - Medicine overview 1668. Nodetrip (previously Xeristar) : Medicine overview 1669. Ganirelix Gedeon Richter - EPAR - Medicine overview 1670. Kymriah : Orphan maintenance assessment report (post authorisation) 1671. Kalydeco : Orphan maintenance assessment report (post-authorisation) (II-0089) 1672. Carvykti : Orphan maintenance assessment report - Post authorisation 1673. Minjuvi : Orphan maintenance assessment report (post authorisation) 1674. Zoonotic Influenza Vaccine Seqirus: EPAR - Risk-management-plan 1675. Epruvy (previously Ranibizumab Midas) 1676. Aucatzyl: EPAR - Risk management plan 1677. Ezmekly: EPAR - Risk management plan 1678. Lynparza : Orphan designation withdrawal assessment report (post-authorisation) 1679. Revlimid : Orphan designation withdrawal assessment report (post-authorisation) 1680. Adcetris : Orphan maintenance assessment report (II-70)